1. Derviševi A, Muhi A, Zairagi A, et al. Red blood cell distribution width-to-platelet ratio inversely correlates with indicators of disease activity status in rheumatoid arthritis patients. Rom J Intern Med 2021; 59(2): 180–186, doi: 10.2478/rjim-2020-0044.
2.
Li X, Xu H, Gao P. Red Blood Cell Distribution Width-to-Platelet Ratio and Other Laboratory Indices Associated with Severity of Histological Hepatic Fibrosis in Patients with Autoimmune Hepatitis: A Retrospective Study at a Single Center. Med Sci Monit 2020; 26: e927946-1–e927946-10, doi: 10.12659/MSM.927946.
3.
Zhu X, Li G, Li S, et al. Neutrophil-to-lymphocyte ratio and red blood cell distribution width-to-platelet ratio predict cardiovascular events in hemodialysis patients. Exp Ther Med 2020; 20(2): 1105–1114, doi: 10.3892/etm.2020.8756.
4.
Angulo M, Moreno L, Aramendi I, et al. Complete Blood Count and Derived Indices: Evolution Pattern and Prognostic Value in Adult Burned Patients. J Burn Care Res 2020; 41(6): 1260–1266, doi: 10.1093/jbcr/iraa091.
5.
Arora S, Patro S, Nath P et al. Red cell distribution width(RDW) to platelet ratio (RPR): A novel marker in early prediction of severity of Acute Pancreatitis. JAPI 2020; 68: 88.
6.
Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012; 302(10): G1075–G1084, doi: 10.1152/ajpgi.00537.2011.
7.
Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512–519, doi: 10.1016/s0140-6736(03)12489-0.
8.
Törnblom H, Lindberg G, Nyberg B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 1972–1979.
9.
Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 1662–1671.
10.
Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17(5): 643–650, doi: 10.1046/j.1365-2036.2003.01456.x.
11.
Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15(3): 237–241.
12.
Aktas G, Alcelik A, Tekce BK, et al. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Prz Gastroenterol 2014; 9: 160–163, doi: 10.5114/pg.2014.43578.
13.
Aktas G, Duman T, Atak B, et al. Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters. Fam Med Prim Care Rev 2020; 22(2): 107–110.
14.
Taefi A, Huang CC, Kolli K, et al. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol Int 2015; 9: 454–460, doi: 10.1007/s12072-015-9638-9.
15.
Karagöz E, Tanolu A, Ülçay A, et al. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 2016; 28(7): 744–748, doi: 10.1097/MEG.0000000000000647.
16.
Zhou WJ, Yang J, Zhang G, et al. Association between red cell distribution width-to-platelet ratio and hepatic fibrosis in nonalcoholic fatty liver disease: a cross-sectional study. Medicine 2019; 98: e16565, doi: 10.1097/md.0000000000016565.
17.
Wang H, Xu H, Wang X, et al. Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis. Medicine 2016; 95: e3114, doi: 10.1097/md.0000000000003114.
18.
Özer Bekmez B, Tayman C, Büyüktiryaki M, et al. A promising, novel index in the diagnosis and follow-up of patent ductus arteriosus: red cell distribution width-to-platelet ratio. J Clin Lab Anal 2018; 32(9): e22616, doi: 10.1002/jcla.22616.
19.
Xie S, Chen X. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus. Medicine 2018; 97: e12342, doi: 10.1097/md.0000000000012342.
20.
Bilgin B, Sendur MAN, Hizal M, et al. Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization. J Cancer Res Ther 2019; 15(1): 54–60, doi: 10.4103/jcrt.JCRT_624_17.
21.
Celk T, Balta S, Demr M, et al. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiol J 2016; 23: 84–92, doi: 10.5603/CJ.a2015.0070.
22.
Takeuchi H, Abe M, Takumi Y, et al. Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer. Sci Rep 2019; 9: 3033, doi: 10.1038/s41598-019-40024-8.
23.
Ge X, Zhu L, Li W, et al. Red Cell Distribution Width to Platelet Count Ratio: A Promising Routinely Available Indicator of Mortality for Acute Traumatic Brain Injury. J Neurotrauma 2022; 39(1–2): 159–171, doi: 10.1089/neu.2020.7481.
24.
Atak BM, Erkus E, Duman TT, et al. Mean Platelet volume to platelet and red cell distribution width to platelet ratios in Irritable Bowel Syndrome. Exp Biomed Res 2018; 1: 60–63.
25.
Ng QX, Soh AYS, Loke W, et al. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res 2018; 11: 345–349, doi: 10.2147/JIR.S174982.
26.
Clarke G, Quigley EM, Cryan JF et al. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 2009; 15(10): 478–489, doi: 10.1016/j.molmed.2009.08.001.
27.
Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 1474–1482, doi: 10.1038/ajg.2012.260.
28.
Gracie DJ, Williams CJ, Sood R, et al. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2017; 15(3): 376–384, doi: 10.1016/j.cgh.2016.05.012.
29.
Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2014; 63: 744–752, doi: 10.1136/gutjnl-2012-304066.
